Depsipeptide (FK228) as a Novel Histone Deacetylase Inhibitor: Mechanism of Action and Anticancer Activity

E-ISSN： 1875-5607|7|10|1062-1069

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.10, 2007-10, pp. : 1062-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines

By Kano Yasuhiko Akutsu Miyuki Tsunoda Saburo Izumi Tohru Kobayashi Hiroyuki Mano Hiroyuki Furukawa Yusuke

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 31-40

Springer Publishing Company

Access to resources Recommend Favorite

Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-04 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A. Popa C. Serewko M.M. Jones S.J. Dicker A.J. Dahler A.L.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

Selective Histone Deacetylase Inhibitors with Anticancer Activity

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 415-12

Bentham Science Publishers

Access to resources Recommend Favorite

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M Otterson Gregory A

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite